True about critical illness myoneuropathy? (Asked twice in the exam)
**Core Concept**
Critical illness myoneuropathy (CIM) is a condition characterized by muscle weakness and wasting in critically ill patients, often due to prolonged immobilization, sepsis, or multi-organ failure. It is distinct from critical illness polyneuropathy (CIP) and is associated with impaired muscle regeneration and repair.
**Why the Correct Answer is Right**
CIM is caused by a combination of factors, including microvascular ischemia, oxidative stress, and inflammation, leading to muscle fiber atrophy and dysfunction. The condition is often accompanied by changes in muscle protein synthesis and degradation pathways, including decreased expression of muscle-specific ubiquitin ligases and increased activity of proteolytic enzymes. The exact pathophysiology of CIM is not fully understood, but it is thought to involve a complex interplay between systemic inflammation, oxidative stress, and muscle-specific factors.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because muscle wasting in CIM is not solely due to disuse atrophy, but rather a complex interplay of systemic and muscle-specific factors.
**Option B:** Incorrect because CIM is not a form of critical illness polyneuropathy (CIP), which affects the peripheral nerves rather than the muscles.
**Option C:** Incorrect because CIM is not a direct result of muscle denervation, but rather a consequence of systemic inflammation and oxidative stress.
**Clinical Pearl / High-Yield Fact**
In critically ill patients, early recognition and management of CIM is crucial to prevent long-term muscle weakness and functional impairment. This can be achieved through early mobilization, nutritional support, and use of neuromuscular electrical stimulation.
**Correct Answer: B. Critical illness myoneuropathy is distinct from critical illness polyneuropathy.**